In Segment A, individuals will get distinct doses and schedules of oral ABBV-744 pill to identify Risk-free dosing program. Extra members will be enrolled on the determined monotherapy dosign program. In Phase B, participants will obtain oral ruxolitinib and ABBV-744 might be given as "incorporate-on" therapy. In Section C, members https://borisd332pak5.wikiitemization.com/user